Drreddys Laboratories | RDY - Trade Creditors


Drreddys Laboratories reported INR22.36B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
ANI Pharmaceuticals USD 73.83M 4.14M Jun/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bayer EUR 6.39B 192M Jun/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cipla INR 32.3B 1.95B Mar/2026
Corcept Therapeutics USD 14.91M 18.4M Jun/2026
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Lonza CHF 471M 3M Dec/2024
Novartis USD 4.26B 64M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 36.85M 14.06M Jun/2026
Richter Gedeon HUF 41.68B 13.96B Mar/2026
Sun Pharmaceuticals INR 73.34B 6.28B Mar/2026
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026